Rovi stock: Barron's cites EUR 76.76 average target for Rovi stock

Published on 10/16/2026 at 17:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half revenue grew 13.20 percent on July 23, 2026. Rovi stock costs EUR 58.15 on October 16, 2026, 0.95 percent above the BME prior close.

Analyst coverage points higher

On October 8, 2026, Barron's listed an average target of EUR 76.76 from 10 ratings.
Rovi reported 13.20 percent first-half revenue growth on July 23, 2026.
Rovi stock costs EUR 58.15 at Lang & Schwarz on October 16, 2026 at 5:02 p.m. CEST, 0.95 percent above the BME prior close of October 15, 2026.
Rovi had a trailing P/E ratio of 16.08 and a dividend yield of 1.65 percent on October 16, 2026.

Rovi, ES0157261019, Illustration mit AI erstellt.

Rovi (ES0157261019) has an average analyst target of EUR 76.76 from 10 ratings, which Barron's reported on October 8, 2026. The average target is 32.00 percent above the Lang & Schwarz price. At Lang & Schwarz, Rovi was EUR 58.15 on October 16, 2026 at 5:02 p.m. CEST, 0.95 percent above the BME prior close of October 15, 2026 at EUR 57.60.

What does the target imply?

On July 23, 2026, Rovi reported total revenue growth of 13.20 percent in the first half of 2026 and gross margin expansion of 6.50 percentage points. That operating comparison gives the analyst target a measurable earnings backdrop, although the target itself reflects expectations rather than a reported result.

Price position on October 16

On BME, the October 16, 2026 trading range was EUR 57.65 to EUR 58.80, while the reported volume was 63,280 shares against an average volume of 104,202. Rovi's 52-week range was EUR 53.10 to EUR 86.70, leaving the Lang & Schwarz price 32.93 percent below the high. The stock was down 8.58 percent year to date on October 9, 2026.

Valuation and next date

Rovi's market capitalization was EUR 3.0 billion on October 16, 2026. The trailing P/E ratio was 16.08 and the dividend yield was 1.65 percent. A master-data listing identifies the issuer as ROVI.MC on BME and assigns ISIN ES0157261019, according to Global Banking and Finance. The next scheduled event is the first nine months 2026 financial results on November 5, 2026, according to Rovi.

Comparison with peers

Rovi: plus 0.95 percent, P/E 16.05, market capitalization EUR 3.0 billion.
Almirall (BME, EUR): minus 0.59 percent, P/E 30.37, market capitalization EUR 2.2 billion.
Faes Farma (BME, EUR): minus 2.85 percent, P/E 11.02, market capitalization EUR 1.5 billion.

Price after the BME close

Rovi was trading at EUR 58.15 at Lang & Schwarz on October 16, 2026 at 5:02 p.m. CEST, 0.95 percent above the BME prior close of October 15, 2026 at EUR 57.60. The further course of trading is shown by the continuously updated real-time quote of Rovi stock.